Paediatric Stevens-Johnson syndrome and toxic epidermal necrolysis: patterns and outcomes in a retrospective Pakistani cohort. [PDF]
Rahman A +6 more
europepmc +1 more source
The case for etanercept in the management of toxic epidermal necrolysis. [PDF]
Uppal E +4 more
europepmc +1 more source
Effective management of pembrolizumab-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap with upadacitinib. [PDF]
Goetz L, Wang B.
europepmc +1 more source
Fatal Pembrolizumab-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in a Patient With Advanced Lung Adenocarcinoma. [PDF]
Chang PC, Chang TW, Kuo CY, Wu YZ.
europepmc +1 more source
Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Mebendazole Use. [PDF]
Heerfordt IM +4 more
europepmc +1 more source
Management of oral lesions in toxic epidermal necrolysis with photobiomodulation: Report of three cases. [PDF]
da Silva WR +5 more
europepmc +1 more source
Low-level laser therapy for the treatment of oral manifestations in a patient with toxic epidermal necrolysis: a case report. [PDF]
Meza V +4 more
europepmc +1 more source
Rechallenge with First-Line Anti-Tubercular Therapy After Toxic Epidermal Necrolysis in an HIV-Positive Patient with Tubercular Pleural Effusion. [PDF]
Narula AS +3 more
europepmc +1 more source
Stevens-Johnson syndrome/toxic epidermal necrolysis induced by tislelizumab: a case report and literature review. [PDF]
Yu H, Li Y, Qu X, Zhu J, Liu Z, Mu Z.
europepmc +1 more source

